Circulating Non-coding RNA in Acute Ischemic Stroke with Endovascular Treatment (EVTRNA)
Clinical Significance of Circulating Non-coding RNA in Acute Ischemic Stroke with Endovascular Treatment (EVTRNA)
Nanjing First Hospital, Nanjing Medical University
300 participants
Mar 15, 2020
OBSERVATIONAL
Conditions
Summary
EVTRNA is to analyze the differentiated expression pattern of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA) by next-generation sequencing in acute ischemic stroke patients before and/or after endovascular treatment. The candidate circRNA/lncRNA/miRNA will be verified as the biomarker and regulator for progression and prognosis of acute ischemic stroke with endovascular treatment. Further, the candidate non-coding RNA will be used to evaluate the effect of endovascular treatment on both peripheral and central immune after stroke.
Eligibility
Inclusion Criteria5
- Aged 18 years or older
- Confirmed acute ischemic stroke by a diffusion-weighted imaging-position lesion on magnetic resonance imaging (MRI) and a new lesion on a brain computed tomography (CT) scan
- Within 24 hours of symptom onset and treat with endovascular therapy
- Good performance status
- Signed an approved informed consents
Exclusion Criteria1
- a history of hemorrhagic infarction, chronic kidney/liver diseases, peripheral arterial occlusive disease, active malignant disease, and inflammatory or infectious diseases
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Next generation sequencing and quantitative real-time polymerase chain reaction of circular RNA (circRNA), long non-coding RNA (lncRNA) and micro-RNA (miRNA)
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04230785